Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Interleukin enhancer-binding factor 3 (ILF3) (C-Term) Peptid

ILF3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN978523

Kurzübersicht für Interleukin enhancer-binding factor 3 (ILF3) (C-Term) Peptid (ABIN978523)

Target

Interleukin enhancer-binding factor 3 (ILF3)

Spezies

Human

Quelle

  • 11
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-ILF3 antibody (Catalog #: ARP32666_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Interleukin enhancer-binding factor 3 (ILF3)

    Hintergrund

    ILF3 may facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. ILF3 can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. ILF3 can regulate protein arginine N-methyltransferase 1 activity. ILF3 may regulate transcription of the IL2 gene during T-cell activation. It can promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA.Nuclear factor of activated T-cells (NFAT) is a transcription factor required for T-cell expression of interleukin 2. NFAT binds to a sequence in the IL2 enhancer known as the antigen receptor response element 2. In addition, NFAT can bind RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the larger of which is the product of this gene. The encoded protein, which is primarily localized to ribosomes, probably regulates transcription at the level of mRNA elongation. Nuclear factor of activated T-cells (NFAT) is a transcription factor required for T-cell expression of interleukin 2. NFAT binds to a sequence in the IL2 enhancer known as the antigen receptor response element 2. In addition, NFAT can bind RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the larger of which is the product of this gene. The encoded protein, which is primarily localized to ribosomes, probably regulates transcription at the level of mRNA elongation. At least three transcript variants encoding three different isoforms have been found for this gene.

    Alias Symbols: DRBF, DRBP76, MMP4, MPHOSPH4, MPP4, NF-AT-90, NF90, NFAR, NFAR-1, TCP80, CBTF, NF110, NF90a, NF90b, NFAR2, NF110b, TCP110

    Protein Interaction Partner: DHX9,EIF2AK2,FUS,GDF9,KRTAP4-12,MAGEA11,MDFI,NDRG1,PLSCR1,PRMT1,SMN2,TRIP6,XPO5,ZNF346,EIF2AK2,FUS,GDF9,HNRNPA1,ILF2,KHDRBS2,KRTAP4-12,MAGEA11,MDFI,MEPCE,PLSCR1,PRKDC,PRMT1,RPAP1,RRP1B,Rrp1b,TRIP6,XPO5

    Protein Size: 894

    Molekulargewicht

    95 kDa

    Gen-ID

    3609

    NCBI Accession

    NM_012218, NP_036350

    UniProt

    Q12906
Sie sind hier:
Chat with us!